BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33730657)

  • 1. Are there common walking gait characteristics in patients diagnosed with late-onset Pompe disease?
    Starbuck C; Reay J; Silk E; Roberts M; Hendriksz C; Jones R
    Hum Mov Sci; 2021 Jun; 77():102777. PubMed ID: 33730657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants and Characterization of Locomotion in Adults with Late-Onset Pompe Disease: New Clinical Biomarkers.
    Maulet T; Cattagni T; Dubois F; Roche N; Laforet P; Bonnyaud C
    J Neuromuscul Dis; 2023; 10(5):963-976. PubMed ID: 37545258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sagittal kinematics and imbalance of the spine and whole body during walking in late-onset Pompe disease.
    De Blasiis P; Fullin A; Mazzoli D; Bruno G; Napolitano F; De Luca A; Melone MAB; Sampaolo S
    J Neurophysiol; 2023 Aug; 130(2):353-363. PubMed ID: 37380604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.
    Jones HN; Hobson-Webb LD; Kuchibhatla M; Crisp KD; Whyte-Rayson A; Batten MT; Zwelling PJ; Kishnani PS
    Mol Genet Metab; 2021 Jul; 133(3):261-268. PubMed ID: 34053870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward deconstructing the phenotype of late-onset Pompe disease.
    Schüller A; Wenninger S; Strigl-Pill N; Schoser B
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):80-8. PubMed ID: 22253010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of gait in late onset Pompe disease.
    McIntosh PT; Case LE; Chan JM; Austin SL; Kishnani P
    Mol Genet Metab; 2015 Nov; 116(3):152-6. PubMed ID: 26372341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
    Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
    Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13 T > G variant.
    Herbert M; Case LE; Rairikar M; Cope H; Bailey L; Austin SL; Kishnani PS
    Mol Genet Metab; 2019 Feb; 126(2):106-116. PubMed ID: 30655185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies.
    Meznaric M; Fumic K; Leonardis L
    J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease.
    Kulessa M; Weyer-Menkhoff I; Viergutz L; Kornblum C; Claeys KG; Schneider I; Plöckinger U; Young P; Boentert M; Vielhaber S; Mawrin C; Bergmann M; Weis J; Ziagaki A; Stenzel W; Deschauer M; Nolte D; Hahn A; Schoser B; Schänzer A
    Neuropathol Appl Neurobiol; 2020 Jun; 46(4):359-374. PubMed ID: 31545528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
    Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
    Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal and kinematic characteristics of gait initiation across a wide speed range.
    Stansfield B; Hawkins K; Adams S; Church D
    Gait Posture; 2018 Mar; 61():331-338. PubMed ID: 29427858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures.
    Vanherpe P; Fieuws S; D'Hondt A; Bleyenheuft C; Demaerel P; De Bleecker J; Van den Bergh P; Baets J; Remiche G; Verhoeven K; Delstanche S; Toussaint M; Buyse B; Van Damme P; Depuydt CE; Claeys KG
    Orphanet J Rare Dis; 2020 Apr; 15(1):83. PubMed ID: 32248831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Late onset Pompe disease: an analysis of 19 patients from Mexico].
    Sánchez-Sánchez LM; Martinez-Montoya V; Sandoval-Pacheco R; Torres-Octavo B; Anaya-Castro DM; Padilla-de la Torre O; Arellano-Valdez CA; Ávila-Rejón CA; Aguilar-Juárez PA; Espino-Pluma M; González-Santillanes Cruz A; Kazakova E; Martinez-Segovia RI; Olmos-Morfin D; Radillo-Díaz PF; Solís-Sánchez I; Vázquez Del Mercado-Espinosa M; Villarroel-Cortés CE; Velarde-Félix JS
    Rev Neurol; 2022 Sep; 75(5):103-108. PubMed ID: 35880963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic respiratory muscle function in late-onset Pompe disease.
    Smith BK; Allen S; Mays S; Martin AD; Byrne BJ
    Sci Rep; 2019 Dec; 9(1):19006. PubMed ID: 31831753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Evaluation of Upright Posture by x-Ray and 3D Stereophotogrammetry with a New Marker Set Protocol in Late Onset Pompe Disease.
    De Blasiis P; Fullin A; Sansone M; Del Viscovo L; Napolitano F; Terracciano C; Lus G; Melone MAB; Sampaolo S
    J Neuromuscul Dis; 2021; 8(6):979-988. PubMed ID: 34120910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.
    Wenninger S; Greckl E; Babačić H; Stahl K; Schoser B
    J Neurol; 2019 Jan; 266(1):133-147. PubMed ID: 30430231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic and clinical studies in patients with late-onset Pompe disease and lower urinary tract symptoms.
    Kuchenbecker KS; Kirschner-Hermanns R; Kornblum C; Jaekel A; Anding R; Kohler A
    Neurourol Urodyn; 2020 Jun; 39(5):1437-1446. PubMed ID: 32343026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower limb sagittal kinematic and kinetic modeling of very slow walking for gait trajectory scaling.
    Smith AJJ; Lemaire ED; Nantel J
    PLoS One; 2018; 13(9):e0203934. PubMed ID: 30222772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.